EFM
E Fund Management Portfolio holdings
AUM
$2.1B
This Quarter Return
+12.44%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(+3.9%)
Cap. Flow
-$33.1M
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
65.03%
Holding
329
New
20
Increased
146
Reduced
123
Closed
37
Top Buys
| 1 |
KLA
KLAC
|
$9.71M |
| 2 |
Pinduoduo
PDD
|
$8.56M |
| 3 |
iShares Gold Trust
IAU
|
$3.24M |
| 4 |
SPDR Gold MiniShares Trust
GLDM
|
$3.14M |
| 5 |
iShares MSCI Global Gold Miners ETF
RING
|
$3.08M |
Top Sells
| 1 |
Grab
GRAB
|
$40.9M |
| 2 |
NVIDIA
NVDA
|
$7.48M |
| 3 |
Microsoft
MSFT
|
$5.75M |
| 4 |
STAAR Surgical
STAA
|
$4.82M |
| 5 |
Sea Limited
SE
|
$3.38M |
Sector Composition
| 1 | Consumer Discretionary | 45.37% |
| 2 | Technology | 25.37% |
| 3 | Communication Services | 8.93% |
| 4 | Healthcare | 6.43% |
| 5 | Real Estate | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Elevance Health
ELV
$71.8B
| $246K | 0.02% |
565
-30
| -5% | -$13.1K |
|
227
Veracyte
VCYT
$2.39B
| $244K | 0.02% |
10,913
-2,172
| -17% | -$48.6K |
|
228
Denali Therapeutics
DNLI
$2.23B
| $243K | 0.02% |
11,781
-1,580
| -12% | -$32.6K |
|
229
PTC Therapeutics
PTCT
$3.92B
| $238K | 0.02% |
10,599
+212
| +2% | +$4.76K |
|
230
CVS Health
CVS
$92.8B
| $234K | 0.02% |
3,345
-100
| -3% | -$7K |
|
231
Celldex Therapeutics
CLDX
$1.47B
| $233K | 0.02% |
8,465
-2,587
| -23% | -$71.2K |
|
232
Wells Fargo
WFC
$263B
| $233K | 0.02% |
5,710
-557
| -9% | -$22.7K |
|
233
Walt Disney
DIS
$213B
| $231K | 0.02% |
2,856
-196
| -6% | -$15.9K |
|
234
Ardelyx
ARDX
$1.53B
| $230K | 0.02% |
56,392
-55,830
| -50% | -$228K |
|
235
Stryker
SYK
$150B
| $228K | 0.02% |
833
-66
| -7% | -$18.1K |
|
236
Nuvalent
NUVL
$5.52B
| $226K | 0.02% |
+4,915
| New | +$226K |
|
237
Philip Morris
PM
$260B
| $225K | 0.02% |
2,426
-167
| -6% | -$15.5K |
|
238
ConocoPhillips
COP
$124B
| $224K | 0.02% |
1,869
-152
| -8% | -$18.2K |
|
239
Mirum Pharmaceuticals
MIRM
$3.71B
| $223K | 0.02% |
+7,050
| New | +$223K |
|
|
CERE
240
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $223K | 0.02% |
10,223
+722
| +8% | +$15.7K |
|
241
Cigna
CI
$80.3B
| $222K | 0.02% |
777
-70
| -8% | -$20K |
|
242
Caterpillar
CAT
$196B
| $218K | 0.02% |
797
-64
| -7% | -$17.5K |
|
243
Vericel Corp
VCEL
$1.83B
| $216K | 0.02% |
+6,433
| New | +$216K |
|
244
Keysight
KEYS
$28.1B
| $214K | 0.02% |
1,620
-127
| -7% | -$16.8K |
|
245
Zscaler
ZS
$43.1B
| $214K | 0.02% |
+1,377
| New | +$214K |
|
|
SWTX
246
DELISTED
SpringWorks Therapeutics
SWTX
| $213K | 0.02% |
9,226
-3,724
| -29% | -$86K |
|
247
Verizon
VZ
$186B
| $213K | 0.02% |
6,570
-451
| -6% | -$14.6K |
|
248
Corning
GLW
$57.4B
| $212K | 0.02% |
6,971
-515
| -7% | -$15.7K |
|
249
Syndax Pharmaceuticals
SNDX
$1.41B
| $212K | 0.02% |
14,594
-3,433
| -19% | -$49.9K |
|
250
Zoetis
ZTS
$69.3B
| $208K | 0.02% |
1,196
-150
| -11% | -$26.1K |
|